[Butyrophenone derivatives].
Hirokane
Genta
G
Department of Psychiatry, Shiga University of Medical Science.
Shimoda
Kazutaka
K
D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D004347:Drug Interactions; D016903:Drug Monitoring / Q000379:methods*; D006220:Haloperidol / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000097:blood*; D006801:Humans; D007124:Immunoenzyme Techniques; D016312:Treatment Refusal
D014150:Antipsychotic Agents; D015415:Biomarkers; D006220:Haloperidol; C006820:bromperidol